Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
6
×
life sciences
national blog main
san diego blog main
6
×
san diego top stories
6
×
biotech
boston blog main
fda
new york blog main
boston top stories
national top stories
new york top stories
startups
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
drugs
indiana blog main
indiana top stories
melinta therapeutics
national
novartis
raleigh-durham blog main
raleigh-durham top stories
rna
san diego
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
achaogen
adams street partners
akcea therapeutics
What
medicines
6
×
drug
company
disease
fda
genetic
ipo
new
rare
therapeutics
year
acquisitions
advance
ago
akcea
alnylam
amgen
amyloidosis
announced
approval
approved
attr
available
bacteria
battle
bio
biologics
biopharma
brings
business
candidates
ceo
class
collabs
considered
covid
daniel
deal
debilitating
deliver
Language
unset
Current search:
medicines
×
" clinical trials "
×
" san diego top stories "
×
" san diego blog main "
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
DTx Pharma Raises $10.6M to Advance New Way to Deliver RNA Drugs
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines